Ironwood Pharmaceuticals Inc. (IRWD) and Allergan plc (AGN) announced positive topline data from a Phase IIb clinical trial evaluating the investigational linaclotide colonic release-1 or CR1 formulation in adult patients with irritable bowel syndrome with constipation or IBS-C.
from RTT - Biotech http://ift.tt/2ieQ5Iu
via IFTTT
No comments:
Post a Comment